Primary objectiveTo compare the Constant scores (reflecting functional outcome and pain) at one year after primary hemiarthroplasty versus non-operative treatment in patients over 65 years of age who sustained a complex humeral fracture.Secondary…
ID
Source
Brief title
Condition
- Fractures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Constant score
Secondary outcome
DASH score, including optional module for sports/music performance
Pain level at both sides (VAS)
Secondary intervention
Radiographic healing
Mortality
Complication rates in HA group: infection, neurovascular injury, malpositioning
of the prosthesis, asceptic loosening of the prosthesis, dislocation of the
tuberculi
Complication rates in control group: malunion, nonunion, secondary dislocation,
symptomatic avascular necrosis (AVN) of the humeral head
SF-36
EQ-5D
Costs and cost-effectiveness
Background summary
Fractures of the proximal humerus are common injuries in the elderly. The
incidence is approximately 6.6 per 1000 person years. Most of these fractures
can be treated with non-operative means and careful early motion. However, the
treatment of complex fractures like selected three-or four-part fractures and
split fractures of the humeral head is a demanding and unresolved problem.
Locking plates have recently been introduced and they appear to offer
improved fixation. However, especially in elderly patients the prevalence of
screw cut-out ranges from 11 to 43% due to fracture collapse. This may
ultimately lead to higher rates of revision surgery. Therefore, it seems
reasonable to treat these complex fractures primarily with a prosthesis or
non-operatively in a population of elderly patients.
Primary hemiarthroplasty and non-operative treatment of complex
proximal humeral fractures have been described in a number of studies with
varying functional results. Stableforth et al. performed a randomized study
comparing hemiarthroplasty with conservative management in a total of 32
patients. The results revealed less pain and better overall function in the
hemiarthroplasty group. However, this study had methodological limitations
because of indistinct inclusion criteria and a difference in age between the
two intervenion arms at baseline, and may therefore not be generalizable. To
our notice no other randomized controlled trial has been performed to compare
hemiarthroplasty and non*operative treatment of complex fractures of the
proximal humerus.
Study objective
Primary objective
To compare the Constant scores (reflecting functional outcome and pain) at one
year after primary hemiarthroplasty versus non-operative treatment in patients
over 65 years of age who sustained a complex humeral fracture.
Secondary objectives
1. To compare the Constant scores (reflecting functional outcome and pain) at
six months and two year after primary hemiarthroplasty versus non-operative
treatment in patients over 65 years of age who sustained a complex humeral
fracture
2. To examine the effect of primary hemiarthroplasty versus non-operative
treatment on the degree of disabilities of the arm, shoulder and hand (DASH
score) as well as on sports/music performance (DASH optional module)
3. To examine the effect of primary hemiarthroplasty versus non-operative
treatment on the level of pain experienced by the patients (VAS)
4. To examine the effect of primary hemiarthroplasty versus non-operative
treatment on the rate of secondary interventions, complications and mortality
5. To examine the effect of primary hemiarthroplasty versus non-operative
treatment on health-related quality of life (SF-36, EQ-5D)
6. To assess the costs and cost-effectiveness ratio of primary hemiarthroplasty
versus non-operative treatment
7. To identify the healing and position of the tuberculi based on CT and
radiographs
Study design
Multicenter randomized controlled trial
Intervention
One group will receive a hemiarthroplasty (Affinis® Fracture shoulder
endoprosthesis (Mathys AG Bettlach)).
Critical aspects of the surgical procedure will be standardized. After surgery,
patients are allowed to use a sling for 2 days to one week. Patients will
receive after-treatment following a standardized approach. Anteflexion and
elevation exercises may be started immediately if tolerated. Rotation exercises
against resistance are not allowed during the first six weeks after surgery.
The other group will be treated non-operatively.
The affected arm will be put in a collar and cuff for three weeks. At one week
after fracture circumduction exercises will start. At three weeks after
fracture mobilization will be initiated by practicing under supervision of a
physical therapist. Physical therapy sessions will be held at regular
intervals, preferably 2 times a week during 12 weeks. The exact frequency and
duration of physical therapy will largely depend upon the extent of functional
recovery. This will be left at the discretion of the therapist.
Study burden and risks
Both interventions are standard of care treatment modalities.
The clinic follow-up visits at t=1, 3 and 6 weeks, and 3, 6, 12 and 24 months
are part of Standard of Care. The same holds true for the X-rays at t=1,3 and 6
weeks, and 3 and 12 months and the pre-operative CT-scan (for fracture
classification).
For research purposes, one single CT scan of the schoulder will be made at 12
monthts in order to assess the degree of radiographic healing. The effective
radiation due to this CT scan is mild. An additional risk associated with
participating in this trial is the completion of a set of questionnaires. There
are no risks involved in that.
's-Gravendijkwal 230
Rotterdam 3015 CE
NL
's-Gravendijkwal 230
Rotterdam 3015 CE
NL
Listed location countries
Age
Inclusion criteria
Patients meeting the following inclusion criteria are eligible for enrolment:
1. Adult men or women aged 65 years and older (with no upper age limit)
2. Fracture of the humeral head
3. Selected three-part (Hertel classification type 9, 10, 11), selected four-part (Hertel type 12), anatomical neck (Hertel type 2), or split-head fractures of the humeral head in the judgement of the attending surgeon. All fractures should be classified according to the binary description system, based on 3D CT reconstructions
4. Operative treatment within 21 days of presenting to the emergency department (if randomized for HA)
5. Provision of informed consent by patient
6. Assurance that the surgeon who will perform HA has attended the pre-trial HA course.
Exclusion criteria
If any of the following criteria applies, patients will be excluded:
1. Polytraumatized patients
2. Patients with an additional traumatic injury of the affected arm
3. Patients with pathological, recurrent or open fractures
4. Patients with an impaired shoulder function (i.e., stiff or painful shoulder, neurologic disorder of the upper limb, or diagnosed rotator cuff impairment) prior to the injury
5. Retained hardware around the affected humerus
6. Patients with a disorder of bone metabolism other than osteoporosis (i.e., Paget*s disease, renal osteodystrophy, osteomalacia)
7. Moderate or severe cognitively impaired patients (i.e., Mini-Mental Status Examination (MMSE) Six Item Screener with 3 or more errors)
8. Likely problems, in the judgment of the investigators, with maintaining follow-up (e.g., patients with no fixed address will be excluded)
9. Insufficient comprehension of the Dutch language to understand a rehabilitation program and other treatment information in the judgment of the attending physician.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL26320.078.09 |
OMON | NL-OMON24819 |